Fremanezumab for the preventive treatment of migraine
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2019.1627323
Abstract: ABSTRACT Introduction: The recent approval of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway introduced the first preventive treatments for migraine that were specifically designed to target the underlying pathophysiology of the disease. Fremanezumab,… read more here.
Keywords: migraine; treatment migraine; preventive treatments; migraine fremanezumab ... See more keywords